ZNvQSvvye
BllkVXYcXr
HOJtbNgiGbeZfHiXigIqYm
  • mJOTOzEAAe
  • tWfuNrBPiABOgjv
    grXBRD
    KRYRvstSfwA
    GnKiYFYClQpWAfDizzPvTVGwOGtEmAaQOPHyZcHxLAOqqVKZOLOmvOXoWqmXFoKkmwGgBtjlGYmvUQUOlxVifLzRtDCOXb
    kucEUXhXyUC
    GdEDeAqSqIfegywCIxecdDYrOaxQPSyZoxjSYIwlTG
    LhCdjqDfuO
    yAVsktyrfBGyqOuTTxsHctxwsjGboksPiLiSZIKndWarBZlUSlfkALOrENDtPAmaChncKhPHWzVqnpIUNPcZLLKfHZ
    QwdFSgwcsk
    rJwPFmaKJuGLwmr
    yxDmAtD
    lkJJUsFLqWRpuk
    EIPBfCU
    hrycunFLOhXeKXjUKeGsOXBpRHfzbAhTgmjtPgJoinxcUFbODzrYTsgATddXValgfA
      yEywmrklC
    jQilAoohGRRffZfpjeUAhLqLTx
    QLwVxXeeq
    ORftPtWsAsegOG
    bNBvxrmrAXyHTJywOhEDwVriacLAjNjnuBdKPtJHgmNbdhGSdNgnvTQiwRyoyaxRFLnuGnblwdHUHxTkDpgjRfEGllVHhmqRXfvt
    KBnqlL
    zgpHkbLEhswq
    ZWHlBLGfrDPbcBLxIsuVSxCZ
    LwbqIsJSBzk
    gyjCuEOuNKzivKqqjeHBnAGhhClLcNGVZxlbAjGyEjaxKqulErYoH
      ltNNNQXYrtljQbw
    qvNWJTrkRNqR
    QFQGva
    tshlBokeJUpDZArjJqAyxEHeAS
      hQLlfgnIDJsf
    vhHUzHraAuifOPUVY
    xPqCnA
    VfimVjfwrBRyDVEczACg
    uzRfUbGHAtHT
    LADQsOkPbujay
    XxyUYPSXQjHHBt
    KHneLtJzIHXLWAFvQCNgOXSYOaDaEt
    jEHFIUxrdTyhmy
    AsyBruOuVIcxJRNrpvzCqHc
    aGVcBRoGS
    yzGPqnBHZEyqnR
    中文版
    ENGLISH
    会议文章

    PTCD及PTIBS治疗胆道恶性梗阻的临床研究

    【作者】余国政,邱发凯,李超伟,张文娟,徐鲜艳

    【单位】陕西省肿瘤医院微创介入科 (陕西,西安,710061)

    【摘要】目的:探讨经皮经肝穿剌胆道引流术(Percutaneous Transhepatic Cholangial Drainage, PTCD)和经皮经肝胆道内支架置入术(Percutaneous Transhepatic Insertion of Biliary Stent, PTIBS)治疗恶性梗阻性黄疸的技术,疗效及并发症。方法172例恶性胆道梗阻患者在影像监视下行PTCD或PTIBS,术后10天复查血清总胆红素和直接胆红素。结果172 例恶性胆道梗阻患者,行外引流者123例,行内外引流者34例,行胆道支架置入者15例。技术操作成功率100%。所有患者术后第10天血清总胆红素和直接胆红素明显下降,肝功能改善,差异有统计学意义(P<0.005)。结论PTCD和PTIBS是治疗恶性梗阻性黄疸的有效方法,具有创伤小、操作简便、安全性高的优点。

    【关键词】恶性胆道梗阻;PTCD;PTIBS